The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted ...

The price of insulin has exponentially increased in recent years. Now, the Federal Trade Commission (FTC) is suing three companies over allegedly inflating ... drive down drug prices for consumers ...

Insulin prices have skyrocketed in recent years, working a hardship on the growing number of diabetics in the US. Progressive ...

The drug middlemen say they’re a necessary counterweight to the unchecked power of pharmaceutical companies to set prices. The insulin market is dominated by three manufacturers: Eli Lilly & Co ...

Anyone who needs insulin to treat diabetes knows that the cost of the drug has skyrocketed in the last few years. The reason ...

No matter what happens in this election, the government should work for the people. The government may not be perfect, but it ...

CVS Health, Cigna and UnitedHealth Group are demanding that FTC Chairwoman Lina Khan and two other commissioners recuse themselves from a lawsuit accusing the company and other drug middlemen of ...

The drug middlemen say they’re a necessary counterweight to the unchecked power of pharmaceutical companies to set prices. The insulin market is dominated by three manufacturers: Eli Lilly & Co., ...